This issue of Our Voice approaches the crucial subject of PSA screening. First results from the two large clinical trials of PSA screening have recently weighed in, and Dr. Tom Pickles guides us through the essential points. When it comes to prostate cancer, nothing is simple: These two studies reported quite different results. The American study found that there was no advantage to PSA testing, while the European study indicated a 20% lower prostate cancer mortality risk in men in the screening group. As Dr. (...)